MENG, X.,
DUAN, C.,
PANG, H.,
CHEN, Q.,
HAN, B.,
MAGAFUROV, D.A.,
WU, P.,
LI, Z.,
ZHAO, S.,
WANG, R.,
LIN, L.,
JIANG, C.,
CAI, J.,
ZHA, C. (2019) Background: DNA damage repair (DDR) alterations are important events in
cancer initiation
YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) carcinoma is one of the most common and lethal
cancer types due to its high degree of malignancy and poor
MENG, X.,
DUAN, C.,
PANG, H.,
CHEN, Q.,
HAN, B.,
MAGAFUROV, D.A.,
WU, P.,
LI, Z.,
ZHAO, S.,
WANG, R.,
LIN, L.,
JIANG, C.,
CAI, J.,
ZHA, C. (2019) Background
DNA damage repair (DDR) alterations are important events in
cancer initiation
Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020) of p53 that is involved in many cellular processes, including apoptosis of
cancer cells.
The purpose
Sharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) provides prospects for the treatment of many neurodegenerative diseases and
cancers that were previously
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) the primary research pathways in the development of new anti-
cancer medications, with a particular focus
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) (OR: 2.25), history of
cancer (OR: 1.93) and dementia (OR: 2.54), higher serum concentration